zidovudine has been researched along with B Virus Infection in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 6 (42.86) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Figg, WD; George, J; Goncalves, P; Lurain, K; Marshall, V; Peer, CJ; Ramaswami, R; Serquiña, A; Steinberg, SM; Uldrick, TS; Wang, V; Whitby, D; Widell, A; Yarchoan, R; Ziegelbauer, J | 1 |
| Hislop, AD; Nicol, SM; Sabbah, S; Stürzl, M; Williamson, SJ | 1 |
| Bisseye, C; Buelli, F; Castelli, F; Gnoula, C; Ilboudo, D; Karou, D; Nikiema, JB; Odolini, S; Ouermi, D; Pietra, V; Pignatelli, S; Sagna, T; Sanou, DS; Sia, DJ; Simpore, J | 1 |
| Aleman, K; Little, RF; Marshall, V; O'Mahony, D; Pittaluga, S; Polizzotto, MN; Steinberg, SM; Tosato, G; Uldrick, TS; Wang, V; Whitby, D; Wyvill, KM; Yarchoan, R | 1 |
| Polizzotto, MN; Uldrick, TS; Yarchoan, R | 1 |
| Fleckenstein, B; Stamminger, T | 1 |
| Chiu, S; Fraser-Smith, EB; Freitas, VR; Michelson, S; Schatzman, RC | 1 |
| Graham, NM; Hoover, DR; Park, LP; Saah, AJ; Stein, DS | 1 |
| Boyer, P; Cooper, E; Goldfarb, J; Hammill, H; Hodes, D; Jenson, H; Kovacs, A; LaRussa, P; McIntosh, K; Peavy, H; Pitt, J; Schluchter, M; Shearer, W; Sperling, R; Tuomala, R | 1 |
| Barber, GN; Boise, LH; Cabral, L; Deyev, VV; Harrington, WJ; Liu, LH; Podack, ER; Scott, D; Toomey, NL; Wood, C | 1 |
| Koziel, MJ; Walker, BD | 1 |
| Lumio, J | 1 |
| Bean, B | 1 |
| Hirschel, B | 1 |
4 review(s) available for zidovudine and B Virus Infection
| Article | Year |
|---|---|
Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
Topics: Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Castleman Disease; Ganciclovir; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Rituximab; Valganciclovir; Zidovudine | 2012 |
Viruses, chemotherapy and immunity.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Microbial; Ganciclovir; Herpesviridae Infections; HIV Infections; HIV-1; Humans; Immunity, Cellular; Interferons; Major Histocompatibility Complex; Virus Diseases; Zidovudine | 1992 |
[Treatment and prevention of HIV infection and related opportunistic infections].
Topics: AIDS-Related Opportunistic Infections; Cryptococcosis; Cytomegalovirus Infections; Female; Herpesviridae Infections; HIV Infections; Humans; Male; Mycobacterium avium-intracellulare Infection; Pneumocystis Infections; Toxoplasmosis; Tuberculosis; Zidovudine | 1992 |
[Antiviral drugs--1988].
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Herpesviridae Infections; Humans; Virus Replication; Zidovudine | 1988 |
1 trial(s) available for zidovudine and B Virus Infection
| Article | Year |
|---|---|
High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.
Topics: Adult; Anti-HIV Agents; Castleman Disease; Drug Therapy, Combination; Female; Ganciclovir; Herpesviridae Infections; Herpesvirus 8, Human; HIV Infections; Humans; Male; Middle Aged; Pilot Projects; Prodrugs; Protein Kinase Inhibitors; Protein Kinases; Survival Analysis; Valganciclovir; Viral Load; Viral Proteins; Virus Activation; Zidovudine | 2011 |
9 other study(ies) available for zidovudine and B Virus Infection
| Article | Year |
|---|---|
Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
Topics: Adult; Anti-HIV Agents; Antibodies, Monoclonal, Humanized; Castleman Disease; Female; Herpesviridae Infections; Herpesvirus 8, Human; HIV Infections; Humans; Interleukin-10; Interleukin-1beta; Male; Middle Aged; Sarcoma, Kaposi; Treatment Outcome; Valganciclovir; Viral Load; Zidovudine | 2020 |
Azidothymidine Sensitizes Primary Effusion Lymphoma Cells to Kaposi Sarcoma-Associated Herpesvirus-Specific CD4+ T Cell Control and Inhibits vIRF3 Function.
Topics: Antiviral Agents; CD4-Positive T-Lymphocytes; Cell Line; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Interferon Regulatory Factors; Lymphoma, Primary Effusion; Polymerase Chain Reaction; Tumor Escape; Viral Proteins; Zidovudine | 2016 |
Mother-to-child HIV and HHV-8 transmission in neonates at Saint Camille Medical Centre in Burkina Faso.
Topics: Adult; Anti-HIV Agents; Burkina Faso; CD4 Lymphocyte Count; DNA, Viral; Female; Herpesviridae Infections; Herpesvirus 8, Human; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Nevirapine; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious; Young Adult; Zidovudine | 2009 |
[Current developments in antiviral chemotherapy. Part 4: Foscarnet, zidovudine, didanosine].
Topics: AIDS-Related Opportunistic Infections; Didanosine; Dose-Response Relationship, Drug; Drug Administration Schedule; Foscarnet; Herpesviridae Infections; HIV Infections; Humans; Zidovudine | 1994 |
Efficacy of ganciclovir in combination with zidovudine against cytomegalovirus in vitro and in vivo.
Topics: Animals; Cytomegalovirus; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Drug Combinations; Female; Ganciclovir; Herpesviridae Infections; Humans; Mice; Muromegalovirus; Regression Analysis; Zidovudine | 1993 |
Acyclovir in human immunodeficiency virus patients.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Drug Therapy, Combination; Herpesviridae Infections; HIV Infections; Humans; Survival Rate; Zidovudine | 1996 |
Maternal and perinatal factors related to maternal-infant transmission of HIV-1 in the P2C2 HIV study: the role of EBV shedding. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV-1 Infection (P2C2 HIV) Study Group.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; CD4-CD8 Ratio; Cohort Studies; Cytomegalovirus; Female; Gestational Age; Herpesviridae Infections; Herpesvirus 4, Human; HIV Infections; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Oropharynx; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Risk Factors; Urine; Uterine Hemorrhage; Virus Shedding; Zidovudine | 1998 |
Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma.
Topics: Antimetabolites, Antineoplastic; Antiviral Agents; Apoptosis; Apoptosis Regulatory Proteins; Arabidopsis Proteins; bcl-X Protein; Biopolymers; Cysteine Endopeptidases; Drug Synergism; Enzyme Activation; Epstein-Barr Virus Infections; Etoposide; Fatty Acid Desaturases; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Herpesviridae Infections; Herpesvirus 4, Human; Herpesvirus 8, Human; HIV Infections; Humans; Immunocompromised Host; Immunologic Factors; Interferon-alpha; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Membrane Glycoproteins; Neoplasm Proteins; Proto-Oncogene Proteins c-bcl-2; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Thymidine; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Virus Infections; Zidovudine | 2001 |
Antiviral therapy. New drugs and their uses.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Amantadine; Antiviral Agents; Chickenpox; Common Cold; Cytomegalovirus Infections; Herpes Simplex; Herpes Zoster; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Influenza, Human; Interferons; Ribavirin; Rimantadine; Thymidine; Vidarabine; Virus Diseases; Zidovudine | 1986 |